A Qualitative Study on Barriers and Facilitators to Postpartum Cardiovascular Disease Risk Screening in Women with Hypertensive Disorders of Pregnancy: Perspectives from Patients and Healthcare Providers

一项关于妊娠期高血压疾病女性产后心血管疾病风险筛查的障碍和促进因素的定性研究:来自患者和医疗保健提供者的视角

阅读:1

Abstract

PURPOSE: To explore the barriers and facilitators to postpartum cardiovascular disease (CVD) risk screening among women with hypertensive disorders of pregnancy (HDP) from both patient and healthcare provider perspectives, with the aim of informing clinical screening strategies, optimizing postpartum care services, and improving maternal health outcomes. PATIENTS AND METHODS: This study employed purposive sampling and was conducted between February and May 2025 at a tertiary hospital in Suzhou, Jiangsu Province, China. Semi-structured, one-on-one interviews were conducted with 15 women diagnosed with HDP at 3-12 months postpartum. In addition, focus group interviews were held with nine healthcare providers from the obstetrics department and community health centers (CHCs, primary care facilities in China). A content analysis approach was used to analyze the qualitative data. RESULTS: Three themes and twelve subthemes emerged: (1) Limited perception of CVD risk, poor ability to screen and apply health information, fear-driven avoidance behavior, conflicting role priorities, and economic burden are individual barriers; (2) lack of guidance from healthcare providers, fragmented and unstandardized postpartum care system are system-level barriers; (3) family history of hypertension, emphasis on personal health, strong family support, and positive experience with past interventions are promoting factors that encourage women to get screened. CONCLUSION: Postpartum CVD risk screening in women with HDP remains inadequate. Strengthening transitional care, integrating structured screening into postpartum guidelines, expanding insurance coverage, and enhancing digital health and provider training are essential to close clinical gaps and improve long-term cardiovascular outcomes.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。